Syndax Pharmaceuticals Ownership | Who Owns Syndax Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Syndax Pharmaceuticals Ownership Summary

Syndax Pharmaceuticals is owned by 104.01% institutional investors, 0.81% insiders. Blackrock is the largest institutional shareholder, holding 9.28% of SNDX shares. Vanguard Health Care Inv is the top mutual fund, with 3.51% of its assets in Syndax Pharmaceuticals shares.

SNDX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Syndax Pharmaceuticals	104.01%	0.81%	-4.82%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	7.91M	9.28%	$162.33M
Wellington management group llp	7.34M	8.61%	$150.67M
Kynam capital management, lp	5.72M	6.71%	$117.47M
Vanguard group	4.80M	5.63%	$98.48M
Avoro capital advisors	3.89M	4.56%	$79.83M
State street	3.62M	4.25%	$74.37M
Eversept partners, lp	3.61M	4.24%	$74.19M
Avidity partners management lp	3.33M	3.91%	$68.47M
Sofinnova investments	2.15M	2.53%	$44.21M
Orbimed advisors	1.93M	2.26%	$39.53M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Foresite capital management iv	875.00K	12.07%	$17.96M
Aisling capital management lp	1.02M	9.11%	$21.04M
Kynam capital management, lp	5.72M	9.06%	$117.47M
Stempoint capital lp	1.41M	8.52%	$28.99M
Eversept partners, lp	3.61M	5.08%	$74.19M
Prosight management, lp	551.54K	3.38%	$11.32M
Saturn v capital management	419.65K	3.26%	$8.62M
Dafna capital management	657.07K	3.22%	$13.49M
Avidity partners management lp	3.33M	2.91%	$68.47M
Lion point capital, lp	65.00K	2.43%	$1.33M

Top Buyers

Holder	Shares	% Assets	Change
Avidity partners management lp	3.33M	2.91%	922.50K
First turn management	640.39K	2.14%	640.39K
Prosight management, lp	551.54K	3.38%	551.54K
Sofinnova investments	2.15M	2.30%	545.13K
Commodore capital lp	825.00K	1.16%	506.15K

Top Sellers

Holder	Shares	% Assets	Change
T. rowe price investment management	283.83K	0.00%	-2.18M
Bvf inc/il	-	-	-1.88M
State street	3.62M	0.00%	-1.20M
Morgan stanley	756.23K	0.00%	-1.06M
Iron triangle partners lp	-	-	-973.06K

New Positions

Holder	Shares	% Assets	Change	Value
First turn management	640.39K	2.14%	640.39K	$13.15M
Prosight management, lp	551.54K	3.38%	551.54K	$11.32M
Silverarc capital management	370.00K	1.79%	370.00K	$7.60M
Point72 asset management	62.50K	0.00%	62.50K	$1.28M
Fox run management	55.84K	0.22%	55.84K	$1.15M

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-13.00
Riggs asset managment	-26.00
Innealta capital	-48.00
Carsonallaria wealth management	-218.00
Truvestments capital	-218.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	225	11.39%	88,858,869	1.79%	104	0.99%	121	10.00%	59	-3.28%
Jun 30, 2024	200	2.56%	87,296,966	-3.26%	102	0.66%	109	-3.54%	60	11.11%
Mar 31, 2024	195	4.28%	90,236,973	1.79%	124	0.77%	113	-4.24%	54	31.71%
Dec 31, 2023	187	-5.56%	88,652,891	24.90%	126	1.22%	118	22.92%	41	-31.67%
Sep 30, 2023	198	15.79%	70,978,190	0.52%	101	0.99%	96	-10.28%	60	57.89%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Health Care Inv	2.99M	3.51%	-1.26M
Vanguard Total Stock Mkt Idx Inv	2.57M	3.01%	-30.12K
iShares Russell 2000 ETF	2.13M	2.49%	-4.79K
SPDR® S&P Biotech ETF	1.89M	2.22%	20.92K
Vanguard Institutional Extnd Mkt Idx Tr	1.25M	1.47%	-4.05K
Fidelity Small Cap Index	841.55K	0.99%	-20.66K
Franklin Biotechnology Discv A(acc)USD	733.21K	0.86%	-
iShares Russell 2000 Growth ETF	730.98K	0.86%	-
Biotech Growth Ord	637.20K	0.75%	-
Franklin US Small Cap Growth Equity	566.58K	0.67%	-5.82K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 14, 2024	Goldan Keith A.	Chief Financial Officer	Buy	$25.04K
Aug 09, 2023	Morrison Briggs	-	Sell	$965.40K
Aug 02, 2023	Meury William	-	Sell	$490.95K
Aug 02, 2023	Meury William	-	Sell	$490.91K
Aug 02, 2023	Meury William	-	Sell	$715.95K

Insider Transactions Trends

Date	Buy	Sell
2024 Q2	-	-
2024 Q1	-	-
2023 Q3	-	5
2023 Q2	-	5
2023 Q1	-	6

SNDX Ownership FAQ

Who Owns Syndax Pharmaceuticals?

Syndax Pharmaceuticals shareholders are primarily institutional investors at 104.01%, followed by 0.81% insiders and -4.82% retail investors. The average institutional ownership in Syndax Pharmaceuticals's industry, Biotech Stocks , is 47.04%, which Syndax Pharmaceuticals exceeds.

Who owns the most shares of Syndax Pharmaceuticals?

Syndax Pharmaceuticals’s largest shareholders are Blackrock (7.91M shares, 9.28%), Wellington management group llp (7.34M shares, 8.61%), and Kynam capital management, lp (5.72M shares, 6.71%). Together, they hold 24.61% of Syndax Pharmaceuticals’s total shares outstanding.

Does Blackrock own Syndax Pharmaceuticals?

Yes, BlackRock owns 9.28% of Syndax Pharmaceuticals, totaling 7.91M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 162.33M$. In the last quarter, BlackRock increased its holdings by 354.33K shares, a 4.69% change.

Who is Syndax Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Foresite capital management iv is Syndax Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 12.07% of its assets in 875K Syndax Pharmaceuticals shares, valued at 17.96M$.

Who is the top mutual fund holder of Syndax Pharmaceuticals shares?

Vanguard Health Care Inv is the top mutual fund holder of Syndax Pharmaceuticals shares, with 3.51% of its total shares outstanding invested in 2.99M Syndax Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools